BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prolias LLC Spins Out Prolias Technologies, Inc., a Life Sciences Research Reagent Supplier to the Cancer Research Community


7/27/2010 9:15:58 AM

FREDERICK, Md., July 27 /PRNewswire/ -- Prolias Technologies, Inc., a life science reagent and services company with a focus on supplying cancer researchers with the highest quality research reagents and unmatched customer service, announced today that it has spun out of Prolias, LLC and become its own entity.

Prolias Technologies, Inc. will strictly operate as a products and services company serving the cancer research community. Currently, Prolias Technologies, Inc. has product lines of antibodies, recombinant and natural fraction proteins, as well as ELISA kits, with service offerings around each of these product families for those requiring custom research reagents.

Being located in Frederick, MD gives Prolias Technologies, Inc. the unique advantage of being local to such institutions as the National Institutes of Health including the National Cancer Institute. Prolias Technologies, Inc. will leverage its central location to supply scientists with the life science research reagents they require.

Joe Hernandez, Chairman, stated, "Spinning Prolias Technologies, Inc. out of Prolias, LLC was a natural move for us, it allows us to deliver a higher degree of customer service to our valued customers and allows us to move into new, previously untapped cancer research reagent markets. In addition, the location of Prolias Technologies, Inc. gives us an innate ability to reach, and ultimately supply, the world class cancer researchers at the NIH and NCI with the high-quality reagents their work requires."

About Prolias Technologies, Inc.

Prolias Technologies, Inc. is a privately held life science reagent and services company dedicated to supply cancer researchers with the highest quality reagents, as well as unmatched customer service. Currently, Prolias Technologies, Inc. has product lines of antibodies, recombinant and natural fraction proteins, as well as ELISA kits with service offerings around each of these product families for those requiring custom research reagents. Additional information is available at www.proliastechnologies.com.

SOURCE Prolias Technologies, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES